• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 1X40; BONE CEMENT, ANTIBIOTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 1X40; BONE CEMENT, ANTIBIOTICS Back to Search Results
Catalog Number 110034355
Device Problem Improper Chemical Reaction (2952)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/17/2020
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Foreign report source: (b)(6).The device manufacturing quality record indicates that the released product met all requirements to perform as intended.The investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Event Description
It was reported that the patient underwent a cement hip hemi arthroplasty.Canal was prepared and cement was mixed as usual per zimmer biomet guidelines.After awaiting approximatively 22 minutes, the cement had still not hardened, therefore, the stem was removed.Indeed, cement fixation was only on the stem component with zero bone integration, causing a wasted stem due to cement failure.No adverse events have been reported as a result of the malfunction.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional and corrected information.D11: associated device : echo hip femoral 11mm, ref: 12-151411, lot: 539080.Centralizer distal positioner, ref: 162657, lot: 677830.The product analysis can't be performed as the product was not returned.Received picture shows the explanted stem with cement on it, however the picture review can't confirm the event.Also, a retain sample of batch: 851dah1704 has been tested in the laboratory under standardized conditions (23°c; rel.Humid >=40 %).No unusual behavior during mixing, handling or setting.The reported behavior of the cement cannot be reproduced.The device manufacturing quality record indicate that the released product met all requirements to perform as intended.A complaint extract was done regarding cement paste too short setting time: 1 complaint (1 product), this one included, has been recorded on refobacin bone cement 1x40 us, reference: 110034355, from 1 jan 2017 to 24 nov 2020.1 complaint (1 product), this one included, has been recorded on refobacin bone cement 1x40 us, reference: 110034355, batch: 851dah1704.According to available data, root cause of the event was unable to be determined.However, there is no evidence that the event is related to the product.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It was reported that the patient underwent a cement hip hemi arthroplasty.Canal was prepared and cement was mixed as usual per zimmerbiomet guidelines.After awaiting approximatively 22 minutes, the cement had still not hardened, therefore, the stem was removed.Indeed,cement fixation was only on the stem component with zero bone integration, causing a wasted stem due to cement failure.No adverse events have been reported as a result of the malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFOBACIN BONE CEMENT R 1X40
Type of Device
BONE CEMENT, ANTIBIOTICS
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key10275895
MDR Text Key199675452
Report Number3006946279-2020-00128
Device Sequence Number1
Product Code MBB
UDI-Device Identifier00880304990197
UDI-Public0880304990197
Combination Product (y/n)N
PMA/PMN Number
K171540
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 11/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/15/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2021
Device Catalogue Number110034355
Device Lot Number851DAH1704
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/05/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ASSOCIATED PRODUCTS LISTED IN H10.; SEE H10.
Patient Age83 YR
-
-